Akèy › Kondisyon Post-COVID (Long COVID) › Arizona
Etid klinik pou Kondisyon Post-COVID (Long COVID) nan Arizona
4 etid pou Kondisyon Post-COVID (Long COVID) ap chèche patisipan nan sit nan Arizona.
Tèks ofisyèl etid la (Anglè)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Helios Clinical Research ( Site 3826), Paradise Valley
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Tucson
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- University of Arizona, Tucson
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06631287Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
- Mayo Clinic in Arizona, Scottsdale
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 5, 2026 · NCT06614309Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.